Overview
A pivotal psychedelic drug research study seeking to understand and improve the lives of those affected by major depressive disorder (MDD). Participation lasts up to 64 weeks. The uASpIRE Study seeks to understand the potential of the study drug to re-wire rapid patterns of brain activity associated with MDD and provide an alternative approach to currently available treatments for depression.
